BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 27016050)

  • 1. PD-1 function in apoptosis of T lymphocytes in canine visceral leishmaniasis.
    Chiku VM; Silva KL; de Almeida BF; Venturin GL; Leal AA; de Martini CC; de Rezende Eugênio F; Dos Santos PS; de Lima VM
    Immunobiology; 2016 Aug; 221(8):879-88. PubMed ID: 27016050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined neutralization of interferon gamma and tumor necrosis factor alpha induces IL-4 production but has no direct additive impact on parasite burden in splenic cultures of human visceral leishmaniasis.
    Singh N; Sundar S
    PLoS One; 2018; 13(6):e0199817. PubMed ID: 29953494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splenic CD4+ T Cells in Progressive Visceral Leishmaniasis Show a Mixed Effector-Regulatory Phenotype and Impair Macrophage Effector Function through Inhibitory Receptor Expression.
    Medina-Colorado AA; Osorio EY; Saldarriaga OA; Travi BL; Kong F; Spratt H; Soong L; Melby PC
    PLoS One; 2017; 12(1):e0169496. PubMed ID: 28103263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular apoptosis and nitric oxide production in PBMC and spleen from dogs with visceral leishmaniasis.
    de Martini CC; de Andrade JT; de Almeida SKM; Oliveira Silva KL; de Rezende Eugenio F; Dos Santos PSP; de Lima VMF
    Comp Immunol Microbiol Infect Dis; 2018 Apr; 57():1-7. PubMed ID: 30017072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-1 and PD-L1 regulate cellular immunity in canine visceral leishmaniasis.
    Oliveira Silva KL; Marin Chiku V; Luvizotto Venturin G; Correa Leal AA; de Almeida BF; De Rezende Eugenio F; Dos Santos PSP; Fabrino Machado G; De Lima VMF
    Comp Immunol Microbiol Infect Dis; 2019 Feb; 62():76-87. PubMed ID: 30711051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-1 regulates leishmanicidal activity and IL-17 in dogs with leishmaniasis.
    Rebech GT; Venturin GL; Siqueira Ito LT; Bragato JP; de Carvalho Fonseca BS; Melo LM; Costa SF; de Rezende Eugênio F; Dos Santos PSP; de Lima VMF
    Vet Immunol Immunopathol; 2020 Jan; 219():109970. PubMed ID: 31733502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-10 receptor blockade controls the in vitro infectivity of Leishmania infantum and promotes a Th1 activation in PBMC of dogs with visceral leishmaniasis.
    de Oliveira Cardoso JM; de Brito RCF; Costa AFP; Siqueira Mathias FA; Soares Reis LE; Vieira JFP; de Oliveira Aguiar Soares RD; Reis AB; Roatt BM
    Mol Immunol; 2021 Sep; 137():20-27. PubMed ID: 34182228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum.
    Fiuza JA; Gannavaram S; Santiago Hda C; Selvapandiyan A; Souza DM; Passos LS; de Mendonça LZ; Lemos-Giunchetti Dda S; Ricci ND; Bartholomeu DC; Giunchetti RC; Bueno LL; Correa-Oliveira R; Nakhasi HL; Fujiwara RT
    Vaccine; 2015 Jan; 33(2):280-8. PubMed ID: 25475955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor alpha neutralization has no direct effect on parasite burden, but causes impaired IFN-γ production by spleen cells from human visceral leishmaniasis patients.
    Singh N; Kumar R; Engwerda C; Sacks D; Nylen S; Sundar S
    Cytokine; 2016 Sep; 85():184-90. PubMed ID: 27372917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular therapy by allogeneic macrophages against visceral leishmaniasis: role of TNF-α.
    Manna PP; Hira SK; Basu A; Bandyopadhyay S
    Cell Immunol; 2014 Jul; 290(1):152-63. PubMed ID: 24996013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-Cellular Exhaustion Markers are Associated with Splenic Microarchitecture Disorganization and Parasite Load in Dogs with Visceral Leishmaniasis.
    de Souza TL; da Silva AVA; Pereira LOR; Figueiredo FB; Mendes Junior AAV; Menezes RC; Mendes-da-Cruz DA; Boité MC; Cupolillo E; Porrozzi R; Morgado FN
    Sci Rep; 2019 Sep; 9(1):12962. PubMed ID: 31506501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
    Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programmed death 1-mediated T cell exhaustion during visceral leishmaniasis impairs phagocyte function.
    Esch KJ; Juelsgaard R; Martinez PA; Jones DE; Petersen CA
    J Immunol; 2013 Dec; 191(11):5542-50. PubMed ID: 24154626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis.
    Nylén S; Maurya R; Eidsmo L; Manandhar KD; Sundar S; Sacks D
    J Exp Med; 2007 Apr; 204(4):805-17. PubMed ID: 17389235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leishmania donovani: impairment of the cellular immune response against recombinant ornithine decarboxylase protein as a possible evasion strategy of Leishmania in visceral leishmaniasis.
    Yadav A; Amit A; Chaudhary R; Chandel AS; Mahantesh V; Suman SS; Singh SK; Dikhit MR; Ali V; Rabidas V; Pandey K; Kumar A; Das P; Bimal S
    Int J Parasitol; 2015 Jan; 45(1):33-42. PubMed ID: 25449949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined in vitro IL-12 and IL-15 stimulation promotes cellular immune response in dogs with visceral leishmaniasis.
    Costa SF; Gomes VO; Dos Santos Maciel MO; Melo LM; Venturin GL; Bragato JP; Rebech GT; de Oliveira Santos C; Nascimento de Oliveira BM; Gileno de Sá Oliveira G; Felix de Lima VM
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0008021. PubMed ID: 31961868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis in T lymphocytes from spleen tissue and peripheral blood of L. (L.) chagasi naturally infected dogs.
    de Lima VM; Fattori KR; de Souza F; Eugênio FR; dos Santos PS; Rozza DB; Machado GF
    Vet Parasitol; 2012 Mar; 184(2-4):147-53. PubMed ID: 21899954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypical Characterization of Spleen Remodeling in Murine Experimental Visceral Leishmaniasis.
    de Melo CVB; Hermida MD; Mesquita BR; Fontes JLM; Koning JJ; Solcà MDS; Benevides BB; Mota GBS; Freitas LAR; Mebius RE; Dos-Santos WLC
    Front Immunol; 2020; 11():653. PubMed ID: 32351510
    [No Abstract]   [Full Text] [Related]  

  • 19. Transcriptional Profiling in Experimental Visceral Leishmaniasis Reveals a Broad Splenic Inflammatory Environment that Conditions Macrophages toward a Disease-Promoting Phenotype.
    Kong F; Saldarriaga OA; Spratt H; Osorio EY; Travi BL; Luxon BA; Melby PC
    PLoS Pathog; 2017 Jan; 13(1):e1006165. PubMed ID: 28141856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD95 (FAS) and CD178 (FASL) induce the apoptosis of CD4+ and CD8+ cells isolated from the peripheral blood and spleen of dogs naturally infected with Leishmania spp.
    Silva KL; Melo LM; Perosso J; Oliveira BB; Santos PS; Eugênio Fde R; Lima VM
    Vet Parasitol; 2013 Nov; 197(3-4):470-6. PubMed ID: 23920055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.